• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Fulcrum Therapeutics, Inc. - Common Stock (NQ:FULC)

    9.060 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 119
    Open 9.060
    Bid (Size) 3.630 (200)
    Ask (Size) 11.00 (100)
    Prev. Close 9.060
    Today's Range 9.060 - 9.060
    52wk Range 2.315 - 12.19
    Shares Outstanding 61,758,994
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Fulcrum Therapeutics to Host Investor Event to Review New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease on December 7, 2025
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Helmerich and Payne, Invivyd, Home Depot And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
     
    Via Benzinga

    Performance

    YTD
    +87.2%
    +87.2%
    1 Month
    +0.4%
    +0.4%
    3 Month
    +39.0%
    +39.0%
    6 Month
    +28.9%
    +28.9%
    1 Year
    +140.3%
    +140.3%

    More News

    Read More
    News headline image
    Why Gorilla Technology Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For October 29, 2025 ↗
    Via Benzinga
    News headline image
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    10 Health Care Stocks Whale Activity In Today's Session ↗
    Via Benzinga
    News headline image
    Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2025
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Fulcrum Therapeutics to Present Preclinical Data for EED Inhibitor FTX-6274 at European Society for Medical Oncology (ESMO) Congress 2025
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Fulcrum Therapeutics to Present at Upcoming Investor Meetings
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Small-Cap Stocks: An Undervalued Opportunity in a Cautious Market?
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Avis Budget Group Posts Downbeat Earnings, Joins SoFi Technologies, Seagate And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Whirlpool Posts Downbeat Earnings, Joins Harmonic, Stanley Black & Decker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2025
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Fulcrum Therapeutics Announces Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Curious about the stocks that are showing activity after the closing bell on Monday? ↗
    Via Chartmill
    News headline image
    Fulcrum Therapeutics to Present Results from the 12 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease
    From Fulcrum Therapeutics, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Fulcrum Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Fulcrum Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Fulcrum Therapeutics, Inc. - Common Stock trade on?
    Fulcrum Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Fulcrum Therapeutics, Inc. - Common Stock?
    The ticker symbol for Fulcrum Therapeutics, Inc. - Common Stock is FULC on the Nasdaq Stock Market
    What is the current price of Fulcrum Therapeutics, Inc. - Common Stock?
    The current price of Fulcrum Therapeutics, Inc. - Common Stock is 9.060
    When was Fulcrum Therapeutics, Inc. - Common Stock last traded?
    The last trade of Fulcrum Therapeutics, Inc. - Common Stock was at 12/03/25 04:00 PM ET
    What is the market capitalization of Fulcrum Therapeutics, Inc. - Common Stock?
    The market capitalization of Fulcrum Therapeutics, Inc. - Common Stock is 559.54M
    How many shares of Fulcrum Therapeutics, Inc. - Common Stock are outstanding?
    Fulcrum Therapeutics, Inc. - Common Stock has 560M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.